EMEA-001161-PIP02-11-M02
Key facts
| Invented name |
Imvanex
|
| Active substance |
Modified Vaccinia Ankara - Bavarian Nordic virus (smallpox)
|
| Therapeutic area |
Vaccines
|
| Decision number |
P/0539/2022
|
| PIP number |
EMEA-001161-PIP02-11-M02
|
| Pharmaceutical form(s) |
Suspension for injection
|
| Condition(s) / indication(s) |
Prevention of smallpox, monkeypox and related orthopoxvirus infection and disease
|
| Route(s) of administration |
Subcutaneous use
|
| Contact for public enquiries |
Bavarian Nordic A/S
E-mail: regulatory@bavarian-nordic.com Tel. +49 89255446300 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|